Assessment of Total Nasal Symptom Score (TNSS) during the Validation of a Novel Aerosolized Cat Dander Environmental Exposure Chamber (EEC) Clinical Model.

被引：0

作者：

Salapatek, A. ^{[1
]}

Nelson, V. ^{[1
]}

McCue, S. ^{[1
]}

Patel, P. ^{[1
]}

机构：

[1] Cetero Res, Mississauga, ON, Canada

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2009年 / 179卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A5704

引用

页数：1

共 12 条

[1] Validation of Aerosolized Cat Dander in an Environmental Exposure Chamber (EEC) Clinical Model
McCue, S.
Wilson, D.
Nelson, V.
Patel, P.
Salapatek, A.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S232 - S232
[2] INDIVIDUAL NASAL SYMPTOMS INCREASE IN CAT ALLERGIC SUBJECTS WHEN EXPOSED TO FEL D 1 IN A VALIDATED AEROSOLIZED CAT DANDER ENVIRONMENTAL EXPOSURE CHAMBER (EEC) CLINICAL MODEL
McCue, S.
Nelson, V.
Wilson, D.
Patel, D.
Salapatek, A.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2009, 103 (05) : A47 - A48
[3] Validation of Fel d 1 Exposure in a Well-Controlled Aerosolized Cat Allergen Environmental Exposure Chamber (EEC)
Nelson, V.
McCue, S.
Salapatek, A.
Patel, P.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S233 - S233
[4] The Mass of Cat Dander Aerosolized is a Good Predictor of the Real-Time Airborne Fel d 1 Concentration in an Environmental Exposure Chamber (EEC).
Wilson, D.
Camuso, N.
Salapatek, A.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB21 - AB21
[5] Consistency and reproducibility of total nasal symptom scores in an environmental exposure chamber (EEC) - experience with desloratadine in clinical studies in the Vienna Challenge Chamber (VCC)
Schmutz, R.
Lemell, P.
Zieglmayer, R.
Horak, F.
Zieglmayer, P.
ALLERGY, 2016, 71 : 339 - 340
[6] Novel Combination Product Captisol-Enabled® Budesonide plus Azelastine HCI Provides Fast, Long-lasting Relief of Allergic Rhinitis Symptoms (Total Nasal Symptom Score (TNSS) and Individual Nasal Symptoms Scores (NSS)) in Ragweed Allergic Patients Studied in an Environmental Exposure Chamber (EEC) Model
Salapatek, A.
D'Angelo, P.
Bates, M.
Patel, D.
Patel, P.
Pipkin, J.
Zimmerer, R.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S130 - S130
[7] Reduction of Re-Aerosolized Household Allergens during Vacuuming with a Product Regime in an Environmental Exposure Chamber (EEC) Model
Sadoway, Tara
Zizek, William
Salapatek, Anne Marie
Nelson, Victoria
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB120 - AB120
[8] Captisol-Enabled® Budesonide nasal spray significantly reduces total nasal (TNSS) and non-nasal symptoms (TNNSS) compared to Rhinocort Aqua® and placebo in ragweed allergic patients in an environmental exposure chamber (EEC) model
Salapatek, A.
McCue, S.
Benz, M.
Eisfeld, B. S.
Mancini, D.
Patel, P.
Pipkin, J. D.
Zimmerer, R.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (01) : A93 - A93
[9] An Aerosolized Cat Allergen Environmental Exposure Chamber (EEC) Model to Study Cat Allergic Patients: Assessment of Airborne Fel d 1 Concentration in Real-time ensures Controlled Patient Exposure to Cat Allergen
Nelson, V.
McCue, S.
Salapatek, A.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (02) : AB128 - AB128
[10] Validation of a novel clinical nonallergic rhinitis (NAR) model to evoke nasal symptoms in an environmental exposure chamber (EEC): part 1-static and dynamic temperature shift regimes
Salapatek, A.
Wilson, D.
Lee, J.
Pozza, L.
Bernstein, J.
Patel, D.
Patel, P.
ALLERGY, 2009, 64 : 210 - 211

← 1 2 →